Pretreatment serum carbohydrate antigen 19-9 concentration is a predictor of survival of patients who have undergone curative resection of stage IV rectal cancer
Digestive Surgery Sep 16, 2017
Miki M, et al. - Authors sought to determine whether pretreatment carcinoembryonic antigen and carbohydrate antigen (CA)19-9 are useful predictors of survival in patients with stage IV rectal cancer who have undergone curative resection. In this study, pretreatment CA19-9 showed good predictive capability for survival after curative resection of stage IV rectal cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
